JP2021502829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502829A5 JP2021502829A5 JP2020544387A JP2020544387A JP2021502829A5 JP 2021502829 A5 JP2021502829 A5 JP 2021502829A5 JP 2020544387 A JP2020544387 A JP 2020544387A JP 2020544387 A JP2020544387 A JP 2020544387A JP 2021502829 A5 JP2021502829 A5 JP 2021502829A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- antigen
- item
- cells
- immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims description 75
- 239000000427 antigen Substances 0.000 claims description 65
- 108091007433 antigens Proteins 0.000 claims description 65
- 102000036639 antigens Human genes 0.000 claims description 65
- 206010028980 Neoplasm Diseases 0.000 claims description 43
- 102000005962 receptors Human genes 0.000 claims description 27
- 108020003175 receptors Proteins 0.000 claims description 27
- 150000007523 nucleic acids Chemical group 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 19
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 16
- 208000035269 cancer or benign tumor Diseases 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 244000052769 pathogen Species 0.000 claims description 9
- 230000001717 pathogenic effect Effects 0.000 claims description 9
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 8
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 230000014509 gene expression Effects 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- 108090000695 Cytokines Proteins 0.000 claims description 6
- 102000004127 Cytokines Human genes 0.000 claims description 6
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 6
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 6
- 230000016396 cytokine production Effects 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 230000004083 survival effect Effects 0.000 claims description 6
- 208000004736 B-Cell Leukemia Diseases 0.000 claims description 5
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 5
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 5
- 208000034578 Multiple myelomas Diseases 0.000 claims description 5
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 5
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 5
- 201000005787 hematologic cancer Diseases 0.000 claims description 5
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims description 5
- 230000003308 immunostimulating effect Effects 0.000 claims description 5
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 4
- 102100037850 Interferon gamma Human genes 0.000 claims description 4
- 108010074328 Interferon-gamma Proteins 0.000 claims description 4
- 102000003814 Interleukin-10 Human genes 0.000 claims description 4
- 108090000174 Interleukin-10 Proteins 0.000 claims description 4
- 108010002350 Interleukin-2 Proteins 0.000 claims description 4
- 102100023123 Mucin-16 Human genes 0.000 claims description 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 4
- 108091008874 T cell receptors Proteins 0.000 claims description 4
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 230000000259 anti-tumor effect Effects 0.000 claims description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 208000003747 lymphoid leukemia Diseases 0.000 claims description 4
- 102000001301 EGF receptor Human genes 0.000 claims description 3
- -1 EGP-40 Proteins 0.000 claims description 3
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims description 3
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 3
- 108091027981 Response element Proteins 0.000 claims description 3
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 3
- 230000001605 fetal effect Effects 0.000 claims description 3
- 230000028993 immune response Effects 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 230000001177 retroviral effect Effects 0.000 claims description 3
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims description 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 2
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 claims description 2
- 108010085238 Actins Proteins 0.000 claims description 2
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 claims description 2
- 101100279855 Arabidopsis thaliana EPFL5 gene Proteins 0.000 claims description 2
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 2
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims description 2
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims description 2
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims description 2
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims description 2
- 102100032912 CD44 antigen Human genes 0.000 claims description 2
- 102100025221 CD70 antigen Human genes 0.000 claims description 2
- 102000024905 CD99 Human genes 0.000 claims description 2
- 108060001253 CD99 Proteins 0.000 claims description 2
- 101150031358 COLEC10 gene Proteins 0.000 claims description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 2
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 2
- 108010009685 Cholinergic Receptors Proteins 0.000 claims description 2
- 101100118093 Drosophila melanogaster eEF1alpha2 gene Proteins 0.000 claims description 2
- 108010055196 EphA2 Receptor Proteins 0.000 claims description 2
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims description 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 2
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 2
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 2
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 2
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 claims description 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 2
- 101100496086 Homo sapiens CLEC12A gene Proteins 0.000 claims description 2
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims description 2
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 claims description 2
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims description 2
- 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 claims description 2
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 2
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 2
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims description 2
- 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 claims description 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 2
- 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 claims description 2
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 2
- 101001005719 Homo sapiens Melanoma-associated antigen 3 Proteins 0.000 claims description 2
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 2
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 2
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 2
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 claims description 2
- 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 claims description 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims description 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims description 2
- 101001094545 Homo sapiens Retrotransposon-like protein 1 Proteins 0.000 claims description 2
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims description 2
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 2
- 101000621309 Homo sapiens Wilms tumor protein Proteins 0.000 claims description 2
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 2
- 102100032816 Integrin alpha-6 Human genes 0.000 claims description 2
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims description 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 2
- 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 claims description 2
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 2
- 102100025082 Melanoma-associated antigen 3 Human genes 0.000 claims description 2
- 108090000015 Mesothelin Proteins 0.000 claims description 2
- 102000003735 Mesothelin Human genes 0.000 claims description 2
- 102100034256 Mucin-1 Human genes 0.000 claims description 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 2
- 102000003729 Neprilysin Human genes 0.000 claims description 2
- 108090000028 Neprilysin Proteins 0.000 claims description 2
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims description 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 2
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims description 2
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 claims description 2
- 102000036673 PRAME Human genes 0.000 claims description 2
- 108060006580 PRAME Proteins 0.000 claims description 2
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 claims description 2
- 102100040120 Prominin-1 Human genes 0.000 claims description 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims description 2
- 101000737809 Rattus norvegicus Cadherin-related family member 5 Proteins 0.000 claims description 2
- 108010002687 Survivin Proteins 0.000 claims description 2
- 102100035721 Syndecan-1 Human genes 0.000 claims description 2
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 2
- 239000004098 Tetracycline Substances 0.000 claims description 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 2
- 102100039094 Tyrosinase Human genes 0.000 claims description 2
- 108060008724 Tyrosinase Proteins 0.000 claims description 2
- 102100022748 Wilms tumor protein Human genes 0.000 claims description 2
- 102000034337 acetylcholine receptors Human genes 0.000 claims description 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
- 229940011871 estrogen Drugs 0.000 claims description 2
- 239000000262 estrogen Substances 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 210000000581 natural killer T-cell Anatomy 0.000 claims description 2
- 210000001672 ovary Anatomy 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 210000003289 regulatory T cell Anatomy 0.000 claims description 2
- 101150047061 tag-72 gene Proteins 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 150000003522 tetracyclines Chemical class 0.000 claims description 2
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 claims 1
- 230000000139 costimulatory effect Effects 0.000 claims 1
- 230000005965 immune activity Effects 0.000 claims 1
- 230000004068 intracellular signaling Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 210000004324 lymphatic system Anatomy 0.000 claims 1
- 230000002611 ovarian Effects 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 description 6
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 3
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762585879P | 2017-11-14 | 2017-11-14 | |
| US62/585,879 | 2017-11-14 | ||
| PCT/US2018/061003 WO2019099483A1 (en) | 2017-11-14 | 2018-11-14 | Il-36 secreting immunoresponsive cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502829A JP2021502829A (ja) | 2021-02-04 |
| JP2021502829A5 true JP2021502829A5 (OSRAM) | 2021-12-23 |
Family
ID=66538783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544387A Pending JP2021502829A (ja) | 2017-11-14 | 2018-11-14 | Ｉｌ−３６を分泌する免疫応答性細胞およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11766474B2 (OSRAM) |
| EP (1) | EP3710020A4 (OSRAM) |
| JP (1) | JP2021502829A (OSRAM) |
| CN (1) | CN111655270A (OSRAM) |
| AU (2) | AU2018367452B2 (OSRAM) |
| CA (1) | CA3082570A1 (OSRAM) |
| WO (1) | WO2019099483A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022545643A (ja) * | 2019-08-13 | 2022-10-28 | キングス・カレッジ・ロンドン | Ｉｌ－１スーパーファミリーのサイトカインの空間時間的に制限された活性が武装化された免疫応答性細胞 |
| WO2021055731A1 (en) * | 2019-09-20 | 2021-03-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Il-36 cytokine expressing oncolytic viruses for treating cancer |
| KR20210058038A (ko) | 2019-11-13 | 2021-05-24 | (주)아모레퍼시픽 | 인터루킨-36 감마를 포함하는 피부 미백용 조성물 |
| US20230338422A1 (en) * | 2020-07-09 | 2023-10-26 | Nanjing Legend Biotech Co., Ltd. | Engineering gamma delta t cells with interleukin-36 for immunotherapy |
| CN112358539A (zh) * | 2020-11-16 | 2021-02-12 | 桂林医学院附属医院 | 一种小鼠截短IL-36γ蛋白及其制备方法 |
| MX2024002436A (es) * | 2021-08-24 | 2024-06-03 | Ecole Polytechnique Fed Lausanne Epfl | Celulas que expresan il-10 para inmunoterapias mejoradas contra el cancer. |
| WO2023109900A1 (en) | 2021-12-17 | 2023-06-22 | Shanghai Henlius Biotech, Inc. | Anti-ox40 antibodies, multispecific antibodies and methods of use |
| JP2025501522A (ja) | 2021-12-17 | 2025-01-22 | シャンハイ・ヘンリウス・バイオテック・インコーポレイテッド | 抗ｏｘ４０抗体及び使用方法 |
| AU2023240941A1 (en) | 2022-03-25 | 2024-09-19 | Shanghai Henlius Biologics Co., Ltd. | Anti-msln antibodies and methods of use |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| JPS6412935A (en) | 1987-07-02 | 1989-01-17 | Mitsubishi Electric Corp | Constant-speed travel device for vehicle |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
| US20130071414A1 (en) | 2011-04-27 | 2013-03-21 | Gianpietro Dotti | Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies |
| KR102198058B1 (ko) * | 2012-10-02 | 2021-01-06 | 메모리얼 슬로안 케터링 캔서 센터 | 면역치료용 조성물 및 방법 |
| KR102363191B1 (ko) * | 2013-02-26 | 2022-02-17 | 메모리얼 슬로안 케터링 캔서 센터 | 면역치료용 조성물 및 방법 |
| EP2997134B1 (en) * | 2013-05-14 | 2020-06-24 | Board of Regents, The University of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| SI3888674T1 (sl) * | 2014-04-07 | 2024-08-30 | Novartis Ag | Zdravljenje raka z uporabo antigenskega himernega receptorja proti-CD19 |
| JP6788573B6 (ja) * | 2014-04-10 | 2020-12-16 | シアトル チルドレンズ ホスピタル， ディービーエー シアトル チルドレンズ リサーチ インスティテュート | メトトレキサートによる選択と組み合わせたＳｌｅｅｐｉｎｇ Ｂｅａｕｔｙトランスポゾンによる遺伝子改変Ｔ細胞の製造 |
| EP3227432B1 (en) * | 2014-12-05 | 2023-10-11 | Memorial Sloan Kettering Cancer Center | Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof |
| EP3227339B1 (en) * | 2014-12-05 | 2021-11-10 | Memorial Sloan-Kettering Cancer Center | Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof |
| MX2018005315A (es) * | 2015-10-30 | 2018-08-14 | Aleta Biotherapeutics Inc | Composiciones y metodos para el tratamiento del cancer. |
| PL3458474T3 (pl) * | 2016-05-18 | 2022-11-14 | Modernatx, Inc. | Kombinacje mrna kodujących polipeptydy immunomodulujące i ich zastosowania |
-
2018
- 2018-11-14 EP EP18878826.9A patent/EP3710020A4/en active Pending
- 2018-11-14 AU AU2018367452A patent/AU2018367452B2/en active Active
- 2018-11-14 CN CN201880086462.6A patent/CN111655270A/zh active Pending
- 2018-11-14 JP JP2020544387A patent/JP2021502829A/ja active Pending
- 2018-11-14 CA CA3082570A patent/CA3082570A1/en active Pending
- 2018-11-14 WO PCT/US2018/061003 patent/WO2019099483A1/en not_active Ceased
-
2020
- 2020-05-13 US US15/930,966 patent/US11766474B2/en active Active
-
2023
- 2023-08-10 US US18/447,439 patent/US20240108705A1/en active Pending
-
2024
- 2024-09-10 AU AU2024219547A patent/AU2024219547A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502829A5 (OSRAM) | ||
| JP7755890B2 (ja) | Ｃａｒ発現ベクター及びｃａｒ発現ｔ細胞 | |
| US20240059754A1 (en) | Chimeric antigen receptors and enhancement of anti-tumor activity | |
| IL314563A (en) | Non-HLA-restricted T-cell receptors and their uses | |
| JP2016508728A5 (OSRAM) | ||
| RU2015140811A (ru) | Композиции и способы иммунотерапии | |
| JPWO2019157454A5 (OSRAM) | ||
| Godfrey et al. | The role of natural killer cells in immunity against multiple myeloma | |
| JP2021502828A5 (OSRAM) | ||
| JP2017523784A5 (OSRAM) | ||
| JPWO2020088631A5 (OSRAM) | ||
| CA2425862A1 (en) | Cd19-specific redirected immune cells | |
| US20210379149A1 (en) | Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell Therapy | |
| EP3394105B1 (en) | Chimeric antigen receptor with cytokine receptor activating or blocking domain | |
| US20230398216A1 (en) | Chimeric activation receptors | |
| Heiblig et al. | Adoptive immunotherapy for acute leukemia: new insights in chimeric antigen receptors | |
| Bisht et al. | Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities | |
| WO2023235440A2 (en) | Compositions and methods comprising chimeric adaptor polypeptides | |
| Chekmasova et al. | Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer | |
| Liegel et al. | Cellular immunotherapy as a therapeutic approach in multiple myeloma | |
| JPWO2022098925A5 (OSRAM) | ||
| Riedle et al. | In vivo activation and expansion of T cells by a bi‐specific antibody abolishes metastasis formation of human melanoma cells in SCID mice | |
| Zöller | Unexpected induction of unresponsiveness by vaccination with transformed Salmonella typhimurium | |
| JPWO2022159791A5 (OSRAM) | ||
| JPWO2023279112A5 (OSRAM) |